SymbolPRE
NamePRENETICS GLOBAL LTD
SectorFINANCE
RegionAsia
IndustryLaboratory Analytical Instruments
Address7/F, K11 ATELIER, 728 KING''S ROAD, QUARRY BAY, K3 000000
Telephone(852) 2210-7188
Fax
Email
Websitehttps://www.prenetics.com
IncorporationUNDEFINED
Incorporated On
Employees
Fiscal Year
Public Since
ExchangesNASDAQ
Auditor
Audit StatusNOT PROVIDED
Reporting Status
CIK0001876431
Description

Prenetics Global Ltd is a diagnostic and genetic testing company. It focuses on bringing health closer to millions of people globally and decentralising healthcare by making the three pillars, namely, Prevention, Diagnostics and Personalized Care, comprehensive and accessible to anyone, anytime and anywhere. It has operations across nine locations, including the United Kingdom, Hong Kong, India, South Africa, and Southeast Asia. The company develops consumer genetic testing and early colorectal cancer screening; provides COVID-19 testing, rapid point of care and at-home diagnostic testing and medical genetic testing.

Additional info from NASDAQ:
Prenetics Global Ltd is a diagnostic and genetic testing company. It focuses on bringing health closer to millions of people globally and decentralising healthcare by making the three pillars, namely, Prevention, Diagnostics and Personalized Care, comprehensive and accessible to anyone, anytime and anywhere. It has operations across nine locations, including the United Kingdom, Hong Kong, India, South Africa, and Southeast Asia. The company develops consumer genetic testing and early colorectal cancer screening; provides COVID-19 testing, rapid point of care and at-home diagnostic testing and medical genetic testing.

2026-08-26 12:38

Prenetics’ IM8 CEO and CFO Purchase $1.0 Million of Shares in the Open Market Following Second Quarter Results

Read more
2026-08-26 12:23

Rosin Brian J 🟢 acquired 23.1K shares of Prenetics Global Ltd (PRE) at $22.80 Transaction Date: Aug 24, 2026 | Filing ID: 058994

Read more
2026-08-26 09:11

New Form 3 - Prenetics Global Ltd <b>Filed:</b> 2026-08-26 <b>AccNo:</b> 0001628280-26-058990 <b>Size:</b> 253 KB

Read more
2026-08-25 01:43

Lo Hoi Chun 🟡 adjusted position in 0 shares (2 derivative) of Prenetics Global Ltd (PRE) at $0.00 Transaction Date: Aug 21, 2026 | Filing ID: 058762

Read more
2026-08-25 01:41

Director Yeung Danny Sheng Wu 🟡 adjusted position in 25.2K shares (1 derivative) of Prenetics Global Ltd (PRE) at $21.40 Transaction Date: Aug 20, 2026 | Filing ID: 058760

Read more
2026-08-21 11:49

New Form S-8 - Prenetics Global Ltd <b>Filed:</b> 2026-08-21 <b>AccNo:</b> 0001628280-26-058342 <b>Size:</b> 990 KB

Read more
2026-08-20 13:00

Prenetics’ IM8 Announces Two-Time Golden Globe-Nominated Actress and Producer Lily Collins as IM8 Global Ambassador and Shareholder in Multi-Year Partnership

Read more
2026-08-18 11:30

Prenetics’ IM8 Reports Q2 2026 Revenue Growth of 288% YoY; Raises FY 2026 IM8 Revenue Guidance to $220–230 Million; July Was the First Month of Positive Consolidated Adjusted Free Cash Flow and Expected to Remain Positive for Q3 and Beyond

Read more
2026-08-12 11:34

New Form 3 - Prenetics Global Ltd <b>Filed:</b> 2026-08-12 <b>AccNo:</b> 0001628280-26-056003 <b>Size:</b> 461 KB

Read more
2026-08-07 12:30

Prenetics to Report Q2 2026 Financial Results on August 18, 2026, Live-Stream Earnings Event on Stocktwits, and Announces Upcoming Conference Participation

Read more